Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease

enthalten in: Neurology | 2022

von Whittington, M. | Campbell, J. | Rind, D. | +3

Performing Cost-Effectiveness Analyses to Support Policy Making : Key Lessons From the Assessment of Aducanumab

enthalten in: Neurology | 2022

von Campbell, J. | Whittington, M. | Pearson, S.

The effectiveness and value of aducanumab for Alzheimer's disease

enthalten in: Journal of managed care & specialty pharmacy | 2021

von Synnott, P. | Whittington, M. | Lin, G. | +2